Publisert 13.06.2019

3D-bioprinting - ERA-NET BlueBio Joint Transnational Call 2019

BlueBio Joint Transnational Call 2019

Regenics AS, Norway, RISE AB Sweden and CitoxiLab AS, Denmark are invited to submit a full proposal for its 3D-bioprinted patch project with HTX, a marine derived bioactive to the ERA-NET BlueBio Joint Transnational Call 2019.  The full proposal submission deadline is 17 September, 2019.

The project proposal is entitled “3D Printed Biomarine Wound Healing Accelerant – AquaHeal3D”

For more info, please contact Karin Giljam, Regenics AS at kg@regenics.no or mobile +47 91809887

Regenics AS have developed clinical proof of efficacy and safety  in human 2 degree burn wounds for our products Collex® and Vernex®.

The procudts are beeing developed as class III devices. WoundClear® is developed as a BLA/EU CP biotech drug.